Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as pemetrexed disodium work in different ways to
stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well pemetrexed disodium works in treating
patients with persistent or recurrent endometrial cancer.